Ticagrelor Tablet Exporter India, Manufacturer, and Global Supplier

For effective cardiovascular care and prevention of blood clots, partnering with a trusted Ticagrelor Tablet Exporter India is crucial. Ticagrelor Tablet is an advanced antiplatelet medication used to prevent heart attacks, strokes, and other thrombotic events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. It works by preventing platelets in the blood from sticking together, thereby reducing the risk of life-threatening clot formation. As a leading Ticagrelor Tablet Exporter India, we ensure every batch is manufactured in WHO-GMP and ISO-certified facilities, maintaining international quality, purity, and efficacy standards.

Uses of Ticagrelor Tablet

• Prevention of Heart Attack and Stroke: Reduces the risk of cardiovascular death in patients with a history of heart disease or stent placement.

• Treatment of Acute Coronary Syndrome (ACS): Used immediately after heart-related procedures like angioplasty to prevent clot recurrence.

• Post-Myocardial Infarction Management: Helps prevent further complications in patients who have previously suffered from heart attacks.

• Stent Thrombosis Prevention: Ensures blood continues to flow smoothly after stent implantation.

• Combination Therapy: Often prescribed along with low-dose aspirin for better platelet inhibition and protection.

As a reputed Ticagrelor Tablet Exporter India, we provide formulations that offer consistent bioavailability, rapid onset of action, and reliable therapeutic outcomes.

Precautions
Before taking Ticagrelor Tablets, patients and healthcare professionals should carefully follow these precautions:

• Medical Guidance Required: Always take under the supervision of a cardiologist or physician.

• Avoid Abrupt Discontinuation: Stopping Ticagrelor suddenly may increase the risk of blood clots, leading to heart attack or stroke.

• Bleeding Risk: Patients should be monitored for signs of bleeding, as the medicine inhibits platelet aggregation.

• Surgery Precaution: Inform your doctor before any surgery or dental procedure, as Ticagrelor can increase bleeding time.

• Drug Interactions: Avoid using with strong CYP3A4 inhibitors (like ketoconazole) or inducers (like rifampicin) without medical advice.

• Pregnancy and Breastfeeding: Should be used only if clearly needed and prescribed by a doctor.

• Alcohol and Smoking: Limit alcohol intake and smoking, as both can reduce cardiovascular benefits.

Being a professional Ticagrelor Tablet Exporter India, we ensure that our products include clear labeling, usage directions, and safety information for both healthcare providers and patients.

Possible Side Effects
Although Ticagrelor Tablets are well-tolerated, some individuals may experience mild to moderate side effects, including:

• Shortness of breath (dyspnea)

• Increased tendency to bruise or bleed

• Dizziness or light-headedness

• Nausea or diarrhea

• Headache

• Slow heart rate (bradycardia)

• Allergic reactions such as rash or itching (rare)

Most of these effects are temporary and manageable under medical guidance. As a responsible Ticagrelor Tablet Exporter India, we ensure that our products meet strict safety and quality benchmarks before reaching global markets.

Why Choose Us?

• WHO-GMP & ISO Certified Facilities: Guaranteeing premium quality and reliability.

• Trusted Ticagrelor Tablet Exporter India: Supplying high-quality cardiovascular medicines across multiple continents.

• Competitive Pricing: Affordable solutions without compromising product standards.

• Custom Packaging & Bulk Availability: Suitable for hospitals, distributors, and government tenders.

• Regulatory Compliance: Adhering to WHO, USFDA, and EU-GMP export guidelines.

• Efficient Global Logistics: Timely delivery to Africa, Asia, Latin America, and the Middle East.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.